Loading clinical trials...
Loading clinical trials...
Twitter use is surprisingly well represented across broad demographic population segments and health-related messages. The promise of using Twitter is that its use is growing rapidly, it allows the investigators to view communications that were impossible to intercept before, and it potentially provides information faster and less expensively than collection from other media channels. Prior work also supports that social media interventions can improve health behavior change (e.g. weight loss, physical activity) and outcomes.The overarching goals of this proposal are to understand the uses and limitations of this communication channel to improve patients' ability to manage their CV health condition.
Use Twitter to deliver high impact CV health related content to improve patient activation and disease management for diabetes.
Age
21 - No limit years
Sex
ALL
Healthy Volunteers
Yes
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Start Date
June 1, 2016
Primary Completion Date
May 1, 2018
Completion Date
August 1, 2018
Last Updated
October 21, 2024
628
ACTUAL participants
Twitter Diabetes Intervention
BEHAVIORAL
Lead Sponsor
University of Pennsylvania
Collaborators
NCT07051005
NCT07241390
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions